The Argus Min Vol Model Portfolio Source link
Mahindra & Mahindra Ltd. led declines in auto stocks on Tuesday amid reports that the India-EU trade deal includes a clause to slash import duty on cars. The Mahindra Thar Roxx. (Handout) M&M’s share price fell as much as 5.07% to ₹3,363.70 apiece on the NSE, even as Nifty Auto index was down 2.18% intraday. […]
Stocks may stay active as Prestige Estates adds a step-down subsidiary, GP Petroleums acquires a warehouse in Haryana, Kesar India expands land holdings in Nagpur, and IRB Infrastructure advances InvIT-led expressway acquisition. Prestige Estates has incorporated TPCM Educare LLP as a step-down subsidiary to carry on real estate development, leasing, and allied activities. GP Petroleums […]
Asian equities edged lower as tariff concerns resurfaced after President Donald Trump threatened to raise levies on South Korean goods. The yen held its gains. The Kospi Index, one of the world’s best-performing benchmarks this year, fell 0.9%, while the South Korean won weakened after four days of gains. Japanese shares fell for a second […]
SPTM offers broader market exposure and holds nearly five times as many stocks as VTV. VTV pays a higher dividend yield and has shown less volatility and drawdown over the past five years. SPTM tilts heavily toward technology, while VTV emphasizes value-oriented sectors. These 10 stocks could mint the next wave of millionaires › The […]
Over the past three months, 11 penny stocks have plunged between 50% and 80%. These underperformers were identified using a targeted screen that focused on stocks with a market capitalisation below Rs 1,000 crore, a share price under Rs 20, and a minimum recent trading volume of 5 lakh shares, highlighting low-priced, actively traded stocks […]
Halozyme Therapeutics and Catalyst Pharmaceuticals are notching double-digit increases in revenue and EPS. With little debt on their balance sheets, these companies can consider acquisitions. Neither stock looks overpriced, with valuations below the sector average. 10 stocks we like better than Halozyme Therapeutics › The biotech sector returned to health in 2025 after years of […]